Cargando…

Biologic Complexity in Sickle Cell Disease: Implications for Developing Targeted Therapeutics

Current therapy for sickle cell disease (SCD) is limited to supportive treatment of complications, red blood cell transfusions, hydroxyurea, and stem cell transplantation. Difficulty in the translation of mechanistically based therapies may be the result of a reductionist approach focused on individ...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gee, Beatrice E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621302/ https://www.ncbi.nlm.nih.gov/pubmed/23589705 http://dx.doi.org/10.1155/2013/694146

Ejemplares similares

The Role of Nutrition in Sickle Cell Disease
por: Hyacinth, H.I., et al.
Publicado: (2010)

Asthma in Sickle Cell Disease: Implications for Treatment
por: Blake, Kathryn, et al.
Publicado: (2011)

New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019)

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
por: Chauhan, Waseem, et al.
Publicado: (2023)

The role of the arginine metabolome in pain: implications for sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2016)

MEK1/2 as a Therapeutic Target in Sickle Cell Disease
por: Zennadi, Rahima
Publicado: (2019)

The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease
por: Cyrus, Cyril
Publicado: (2021)

SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
por: Andrades, Alvaro, et al.
Publicado: (2023)

Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease
por: Khasabova, Iryna A., et al.
Publicado: (2022)

Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases
por: Alabi, Oladeji John, et al.
Publicado: (2022)

Newborn Screening for Sickle Cell Disease in Europe
por: Daniel, Yvonne, et al.
Publicado: (2019)

Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
por: Ferraresi, Marta, et al.
Publicado: (2023)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
por: Castellani, Giorgia, et al.
Publicado: (2023)

Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications
por: Gürsel, Demirkan B., et al.
Publicado: (2011)

Trauma and Stem Cells: Biology and Potential Therapeutic Implications
por: Thurairajah, Kabilan, et al.
Publicado: (2017)

Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia
por: Imaga, Ngozi Awa
Publicado: (2013)

Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype
por: Driss, A, et al.
Publicado: (2009)

Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications
por: Lau, Eunice Yuen-Ting, et al.
Publicado: (2017)

Structural biology of SARS-CoV-2 and implications for therapeutic development
por: Yang, Haitao, et al.
Publicado: (2021)

ALK in Neuroblastoma: Biological and Therapeutic Implications
por: Trigg, Ricky M., et al.
Publicado: (2018)

Tumor Dormancy: Biologic and Therapeutic Implications
por: Balayan, Vanshika, et al.
Publicado: (2022)

Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
por: Aprile, Annamaria, et al.
Publicado: (2022)

Implications of COVID-19 infections in sickle cell disease
por: John, Nitin Ashok, et al.
Publicado: (2020)

Targeting sickle cell disease root-cause pathophysiology with small molecules
por: Saunthararajah, Yogen
Publicado: (2019)

Sickle Cell Disease and Pregnancy
por: Jain, Dipty, et al.
Publicado: (2019)

Asthma in Sickle Cell Disease
por: Newaskar, Manisha, et al.
Publicado: (2011)

Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
por: Amanullah, Ayeman, et al.
Publicado: (2022)

Therapeutic advances in sickle cell disease in the last decade
por: Shet, Arun S., et al.
Publicado: (2017)

Potential therapeutic action of nitrite in sickle cell disease
por: Wajih, Nadeem, et al.
Publicado: (2017)

The future of sickle cell disease therapeutics rests in genomics
por: Wonkam, Ambroise
Publicado: (2023)

The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications
por: Wang, Qinhong, et al.
Publicado: (2021)

Cancer cell metabolism: implications for therapeutic targets
por: Jang, Miran, et al.
Publicado: (2013)

The gut microbiome in sickle cell disease: Characterization and potential implications
por: Brim, Hassan, et al.
Publicado: (2021)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Whole Blood Transcriptome Analysis in Children with Sickle Cell Anemia
por: Gee, Beatrice E., et al.
Publicado: (2022)

Pathology of Sickle Cell Disease
por: Lebowitz, Paul
Publicado: (1972)

The glomerulopathy of sickle cell disease
por: Ataga, Kenneth I, et al.
Publicado: (2014)

Prevalence of sickle cell disease and sickle cell trait in national neonatal screening studies
por: Lervolino, Luciana Garcia, et al.
Publicado: (2011)

The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
por: Ilie, Mirela Diana, et al.
Publicado: (2019)

Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches
por: Steinberg, Martin H.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qer6n5laqpgbos0sd2v3fs94hv